| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/01/2011 | EP2099796B1 Aza-indolyl compounds and methods of use |
| 06/01/2011 | EP2015775B1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody |
| 06/01/2011 | EP1904060B1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 06/01/2011 | EP1785484B1 Oligonucleotide inhibiting tumor cell proliferation and method therefor |
| 06/01/2011 | EP1584925B1 Novel screening method |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | EP1337525B1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/01/2011 | EP1259265B1 Nucleic acid formulations for gene delivery |
| 06/01/2011 | CN1876177B Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses |
| 06/01/2011 | CN102083840A Antitumoral macrolides |
| 06/01/2011 | CN102083835A Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-A]pyrimidines, methods for preparation and uses thereof |
| 06/01/2011 | CN102083831A Naphthyridininones as AURORA kinase inhibitors |
| 06/01/2011 | CN102083829A Improved Raf inhibitors |
| 06/01/2011 | CN102083828A Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors |
| 06/01/2011 | CN102083814A Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| 06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
| 06/01/2011 | CN102083804A 5-phenyl-isoxazole-3-carboxamides modulating HSP90 with antitumoral activities |
| 06/01/2011 | CN102083801A Quinazoline derivatives and methods of treatment |
| 06/01/2011 | CN102083800A Heteroaryl compounds and uses thereof |
| 06/01/2011 | CN102083799A Benzimidazole derivatives used as FXR agonists |
| 06/01/2011 | CN102083780A Diglycidic ether derivative therapeutics and methods for their use |
| 06/01/2011 | CN102083773A {F-19} -labeled L-glutamic acid and L-glutamine derivative (III), use thereof and method for obtaining them |
| 06/01/2011 | CN102083499A Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor |
| 06/01/2011 | CN102083468A Polymer paclitaxel conjugates and methods for treating cancer |
| 06/01/2011 | CN102083465A Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 06/01/2011 | CN102083464A Cytotoxic immunoglobulin |
| 06/01/2011 | CN102083451A Suppression of cancers |
| 06/01/2011 | CN102083448A Immunotherapeutic agent and immunotherapy for pancreatic cancer |
| 06/01/2011 | CN102083442A Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 |
| 06/01/2011 | CN102083436A Anti-tumour compositions and methods |
| 06/01/2011 | CN102083430A Anti-tumoural effects of cannabinoid combinations |
| 06/01/2011 | CN102083429A Ido inhibitors |
| 06/01/2011 | CN102083428A Methods of treatment employing prolonged continuous infusion of Belinostat |
| 06/01/2011 | CN102083427A Inhibitors of carbonic anhydrase IX |
| 06/01/2011 | CN102083426A Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents) |
| 06/01/2011 | CN102083424A Methods and use of inducing apoptosis in cancer cells |
| 06/01/2011 | CN102080098A Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation |
| 06/01/2011 | CN102080086A Human miR-133a antisense nucleic acid and application thereof |
| 06/01/2011 | CN102080085A Human miR-193b antisense nucleotide and application thereof |
| 06/01/2011 | CN102080084A Human miR-125a-5p antisense nucleotide and application thereof |
| 06/01/2011 | CN102080083A Human miR-149 antisense nucleotide and application thereof |
| 06/01/2011 | CN102080082A Human miR-129* antisensenucleic acid and applications thereof |
| 06/01/2011 | CN102079793A Method for preparing sinonovacula constricta lamarck polysaccharide with various biological activities |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102079787A Antihuman CD52 engineering antibody, carrier, kit and application thereof |
| 06/01/2011 | CN102079772A Pentacyclic triterpene-13,28-lactone compounds as well as preparation method and application thereof |
| 06/01/2011 | CN102079771A Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof |
| 06/01/2011 | CN102079761A Water-soluble S, S-heptaplatin derivative |
| 06/01/2011 | CN102079759A 6-substituted quinazoline derivative, preparation method and application thereof |
| 06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 06/01/2011 | CN102079744A Deuterated achiral crizotinib and derivatives, preparation method and application thereof |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN102079739A Daidzein derivative, preparation method and application thereof |
| 06/01/2011 | CN102079700A Method for synthesizing novel tetracyclic diterpene compound from stevioside |
| 06/01/2011 | CN102078621A Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078602A Antitumor composite and preparation method thereof |
| 06/01/2011 | CN102078601A Anti-tumor composition and preparation method thereof |
| 06/01/2011 | CN102078600A Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same |
| 06/01/2011 | CN102078587A High-efficiency tumor-eliminating pill |
| 06/01/2011 | CN102078570A Medicine for treating hysteromyoma |
| 06/01/2011 | CN102078569A Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof |
| 06/01/2011 | CN102078560A Compound cantharis total extract preparation and preparation method thereof |
| 06/01/2011 | CN102078542A Traditional Chinese medicine combination for treating acute granulocyte AML-M4 leukemia |
| 06/01/2011 | CN102078532A Chinese medicine composition for treating cardiac cancer |
| 06/01/2011 | CN102078530A Traditional Chinese medicine combination for treating acute granulocyte AML-M2 leukemia |
| 06/01/2011 | CN102078517A Traditional Chinese medicine for treating tumor |
| 06/01/2011 | CN102078445A Extraction method of anti-tumor components in stellera chamaejasme L. |
| 06/01/2011 | CN102078444A Preparation method of Chinese stellera root total flavonoids |
| 06/01/2011 | CN102078411A Preparation method of spreading hedyotis herb injection |
| 06/01/2011 | CN102078410A Preparation method of ginseng and spreading hedyotis herb injection |
| 06/01/2011 | CN102078409A Traditional Chinese medicine preparation for treating liver cancer |
| 06/01/2011 | CN102078394A Aconite extract-containing medicinal composition, preparation method and application thereof |
| 06/01/2011 | CN102078387A Traditional Chinese medicine for treating fibroid and ovarian cyst |
| 06/01/2011 | CN102078368A Chinese traditional medicine extract preparation for treating cancer and preparation method thereof |
| 06/01/2011 | CN102078353A Preparation method of musk toad Chinese medicinal capsule |
| 06/01/2011 | CN102078352A Composition for treating cancers |
| 06/01/2011 | CN102078351A Composition for treating cancer |
| 06/01/2011 | CN102078345A Preparation method of actinidia arguta flavonoids |
| 06/01/2011 | CN102078328A Use of potassium ferricyanide in preparing medicine for inhibiting tumor cell metastasis |
| 06/01/2011 | CN102078324A Medicament capable of treating liver cancer |
| 06/01/2011 | CN102078318A Application of 5-substituted-2,4-thiazolidinedione compound in preparation of IGF1R (insulin-like growth factor 1 receptor) function regulating medicaments |
| 06/01/2011 | CN102078317A Dihydroartemisinine-phospholipid complex and preparation and application thereof |
| 06/01/2011 | CN102078316A Application of epigallocatechin gallate derivative in antineoplastic drug |
| 06/01/2011 | CN102078312A Curcumin compound dry powder inhaler as well as preparation method and application thereof |
| 06/01/2011 | CN102078306A Taxol nanoparticle freeze-drying preparation containing recombinant human serum albumin |
| 06/01/2011 | CN102078305A 苯达莫司汀冻干药物组合物 Bendamustine lyophilized pharmaceutical composition |
| 06/01/2011 | CN102078302A Method for preparing berbamine chitosan-agar nano particles |
| 06/01/2011 | CN102078301A Taxotere nano preparation carried by albumin and phospholipid and method preparing same |
| 06/01/2011 | CN102078295A Productive technology of docetaxel injection |
| 06/01/2011 | CN102078294A Polyenic taxusol fat emulsion intravenous solution |
| 06/01/2011 | CN102078293A Taxol solution preparation coordinated with fat emulsion for injection |
| 06/01/2011 | CN102077986A Fig leaf oral liquid |
| 06/01/2011 | CN102077901A Swine hemoglobin enzymolysis and decoloration method |
| 06/01/2011 | CN101822806B Traditional Chinese medicine composition for treating lung cancer and preparation method thereof |
| 06/01/2011 | CN101716178B Antitumor medicament |
| 06/01/2011 | CN101653569B Medicine for curing bladder neoplasm |
| 06/01/2011 | CN101633675B Preparation and application of 5-substituent group-6-substituent phenyl-2-ferrocenyl pyrazolo [1, 5-a] pyrazine-4(5H)-ketone derivative |
| 06/01/2011 | CN101485645B Elemene transdermal agent and preparation method thereof |